Search

The physical phenomena in which an extra electron is removed from a negative ion is called photo‐detachment. Photo‐detachment is important phenomena, used to find the structure of anions, particularly to find the electron affinities. In this paper, we present theoretically the induced effects in the photo‐detached of triatomic anion H3− near hard reflecting wall or surface. For the photo‐detachment process, a z‐polarized coherent source of radiations (laser) is used to kick electrons from H3− anion in the domain of a hard reflecting surface. Imaging method is adopted to derive the generalized detached electron wave, differential cross‐section and the total photo detachment cross‐section analytically. Numerical solutions (simulations) for total electron flux and the total cross‐section is presented. The electron flux, shows visible oscillations and hence the induced effect of surface in the interference. It is depicted that the reflecting hard wall strongly affects the flux and total photo‐detachment cross‐section. The analytical results are extended for triiodide I3− anion numerically, which also show interference. The total photo detachment cross‐section for I3− is calculated numerically and compared with cross‐section of H3−. [ABSTRACT FROM AUTHOR]

Over the past 5 years, sodium‐glucose cotransport 2 (SGLT2) inhibitors have been increasingly regarded as glycaemic agents with cardiovascular (CV) and renal protective effects. The CV benefits of SGLT2 inhibitors have been well established in patients with type 2 diabetes (T2D) and a range of CV comorbidities at baseline. Subsequently, the renal benefits of SGLT2 inhibitors were established in the CREDENCE trial, a dedicated renal outcome trial where canagliflozin reduced the primary composite renal outcome by 30%. In light of these trials, clinical practice guidelines have rapidly evolved, recommending the use of SGLT2 inhibitors as renal and cardioprotective agents in appropriate patient populations. Accordingly, it is important to have an in‐depth understanding of the evidence underlying the use of SGLT2 inhibitors in patients with T2D based on published clinical trials and real‐world evidence (RWE) studies, as well as information related to potential safety concerns. To accomplish this, we reviewed the evidence for renal protection and safety with SGLT2 inhibitors in the EMPA‐REG OUTCOME, CANVAS Program and DECLARE‐TIMI 58 CV safety trials, and in the growing body of evidence emerging from real‐world studies. This body of work has shown that SGLT2 inhibitors reduce the risk of surrogate renal endpoints such as albuminuria and mitigate the risk of hard renal endpoints including doubling of serum creatinine and end‐stage kidney disease in patients with T2D. [ABSTRACT FROM AUTHOR]

The effects of time elapsed after milking and lactation stage were assessed on the lactoperoxidase (LP) enzyme activity and concentrations of thiocyanate in Sahiwal cattle ( N = 15) and Nili-Ravi buffaloes ( N = 15). The LP activity and thiocyanate concentrations decreased as the time elapsed after milking ( P < 0.05) but the concentration of these components increased as the lactation advanced. The LP enzyme activity was sufficient until 12 h post milking but the thiocyanate concentration after 8 h decreased to an insufficient level to activate the LP System, hence additional thiocyanate would be beneficial from external sources. No difference was noted regarding the LPS activity in cattle and buffaloes at the time of collection and subsequently after storage. However, at the end of lactation, the thiocyanate concentration was lower in buffaloes than that in cattle. ( P < 0.05). [ABSTRACT FROM AUTHOR]

AbstractAlthough neurogenic pulmonary oedema is an uncommon condition, it is found in 20% of victims with severe head injury. The onset is typically rapid with development of dyspnoea, cyanosis and hypoxia suddenly and unexpectedly after an intracranial injury. The pathogenesis is not entirely clear, but both increased hydrostatic pressure and capillary permeability are incriminated. It is important to differentiate neurogenic pulmonary oedema from aspiration pneumonia, because the treatment of the two conditions differ. A combination of measures to reduce intracranial pressure, optimize body oxygenation, decrease pre- and after-load and improve cardiac contractility is the mainstay of treatment. Mortality is high despite these measures. [ABSTRACT FROM AUTHOR]

Calcium (Ca 2+ ) has been observed as the most important ion involved in a series of cellular processes and its homeostasis is critical for normal cellular functions. Mitochondrial calcium uniporter (MCU) complex has been recognized as the most important calcium-specific channel located in the inner mitochondrial membrane and is one of the major players in maintaining the Ca 2+ homeostasis by transporting Ca 2+ across the mitochondrial membrane. Furthermore, dysregulation of the mitochondrial Ca 2+ homeostasis has been orchestrated to neurodegenerative response. This necessitates quantitative evaluation of the MCU-dependent mROS production and subsequent cellular responses for more specific therapeutic interventions against neurodegenerative disorders. Towards this goal, here we present a biological regulatory network of MCU to dynamically simulate the MCU-mediated ROS production and its response in neurodegeneration. Previously, ruthenium complex RuRed and its derivatives have been reported to show low nM to high µM potency against MCU to maintain cytosolic Ca 2+ (cCa 2+ ) homeostasis by modulating mitochondrial Ca 2+ (mCa 2+ ) uptake. Therefore, structural modeling and dynamic simulation of MCU pore-forming subunit is performed to probe the interaction profiling of previously reported Ru265 and its derivatives compounds with MCU. The current study highlighted MCU as a potential drug target in neurodegenerative disorders. Furthermore, ASP261 and GLU264 amino acid residues in DIME motif of MCU pore-forming subunits are identified as crucial for modulating the activity of MCU in neurodegenerative disorders., (© 2024 John Wiley & Sons Ltd.)